Sign In

Gregory Fiore

Chief Executive Officer at Exacis Biotherapeutics

Gregory Fiore is a Harvard-trained MD with extensive experience in business leadership and development, clinical research, drug safety, benefit/risk management, and medical affairs.

As a biotech CEO and CMO, he has a demonstrated track record in founding and leading successful companies like Exacis Biotherapeutics and Sollis Therapeutics.

His expertise spans areas such as CV/Renal, intensive care medicine, rare diseases like cystic fibrosis, analgesia, anti-infective, and research governance.

Gregory has a strong background in drug safety and pharmacovigilance, having served as a head of safety for over 10 companies, overseeing safety governance, PV system design, and successful health authority inspections.

In the field of benefit/risk management, he has worked on a range of therapeutic areas including CV, anesthesia/critical care, neuroscience, women's health, oncology, and more.

His involvement in medical affairs includes launch planning, MSL and Med Info strategy, customer feedback capture, publications, and Phase IV activities.

Gregory Fiore's educational background includes a clinical fellowship in Pulmonary/Critical Care and an Internal Medicine residency at Harvard Medical School, where he also graduated as a Class Valedictorian with an MD from New York Medical College.

He has held various leadership positions in organizations such as CEO at Exacis Biotherapeutics, CMO at Synspira, and founder of Fiore Healthcare Advisors and SSI Strategy.

Gregory's career has also seen him in roles like Chief Medical Officer at The Medicines Company, Head of Pharmacovigilance at Merck, and as an Associate Medical Director at Abbott Laboratories.

With his background as a management consultant at McKinsey & Company and as an angel investor, Gregory Fiore brings a wealth of experience and expertise to the biotech and pharmaceutical industry.

Gregory Fiore
Add to my network

Location

Boston, Massachusetts, United States